Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
+22.83%
Latest
+22.83%
3 months
Pareto SecuritiesDanske BankCarnegieBryan GarnierDanske Bank Markets

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
Pareto Securities312 SEKJan 31
+22.83%
Danske Bank403 SEKOct -22
Carnegie360 SEKOct -22
Bryan Garnier400 SEKFeb -22
Danske Bank Markets448 SEKJun -21

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion